ResMed announced at the 35th annual J.P. Morgan Healthcare Conference that the U.S. Food and Drug Administration has cleared the company's AirMini, the world's smallest continuous positive airway pressure (CPAP) device. The company's tiny yet fully-featured AirMini, to be launched later this year, is designed as a secondary CPAP, making it easier for people to continue their sleep apnea therapy while traveling. As an addition to the company's Air Solutions portfolio, the AirMini offers multiple benefits to home medical equipment providers — supporting increased therapy compliance and convenience for their patients, and incremental revenue opportunities.